Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anuncia Medical's ReFlow® devices, including ReFlow® System Mini, ReFlow® Mini Flusher, and ReFlow® EVD, enable noninvasive flushing to prevent shunt occlusions in hydrocephalus patients, reducing revision surgeries. Devices have FDA clearance and Breakthrough Device Designation, with clinical data showing up to six years of success and ongoing studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anuncia Medical.